124 related articles for article (PubMed ID: 12791412)
1. Pharmacokinetics, in-situ absorption and protein binding studies of a new neuroleptic agent centbutindole in rats.
Issar M; Singh SK; Mishra B; Gupta RC
Eur J Pharm Sci; 2003 Jun; 19(2-3):105-13. PubMed ID: 12791412
[TBL] [Abstract][Full Text] [Related]
2. In-situ absorption, protein binding and pharmacokinetic studies of S002-853, a novel antidiabetic and antidyslipidaemic flavone derivative in rats.
Gautam N; Kushwaha HN; Pratap R; Singh SK
J Pharm Pharmacol; 2010 May; 62(5):604-9. PubMed ID: 20609062
[TBL] [Abstract][Full Text] [Related]
3. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
Bae SK; Lee SJ; Kim JW; Kim YH; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 Mar; 26(2):77-83. PubMed ID: 15617135
[TBL] [Abstract][Full Text] [Related]
5. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
6. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and in-situ absorption studies of a new anti-allergic compound 73/602 in rats.
Paliwa JK; Dwivedi AK; Singh S; Gutpa RC
Int J Pharm; 2000 Mar; 197(1-2):213-20. PubMed ID: 10704808
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
[TBL] [Abstract][Full Text] [Related]
9. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.
Zhang H; Yao M; Morrison RA; Chong S
Arch Pharm Res; 2003 Sep; 26(9):768-72. PubMed ID: 14560928
[TBL] [Abstract][Full Text] [Related]
10. A sensitive LC assay for the simultaneous determination of centbutindole and its metabolite in rat serum using fluorescence detection.
Issar M; Singh SK; Mishra B; Gupta RC
J Pharm Biomed Anal; 2002 Jan; 27(1-2):347-53. PubMed ID: 11682243
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
[TBL] [Abstract][Full Text] [Related]
12. Hepatic and intestinal first-pass effects of oltipraz in rats.
Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1α,25-Dihydroxyvitamin D3 on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats.
Yoon IS; Son JH; Kim SB; Choi MK; Maeng HJ
Biol Pharm Bull; 2015; 38(11):1732-7. PubMed ID: 26521823
[TBL] [Abstract][Full Text] [Related]
14. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
Tang-Liu DD; Richman JB; Lin P; Selim S
Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
[TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.
Han KS; Kim YG; Yoo JK; Lee JW; Lee MG
Biopharm Drug Dispos; 1998 Nov; 19(8):493-500. PubMed ID: 9840211
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences.
Hao T; Ling Y; Wu M; Shen Y; Gao Y; Liang S; Gao Y; Qian S
Eur J Pharm Sci; 2017 Apr; 101():71-79. PubMed ID: 28185989
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of centbutindole (neuroleptic) in rats after oral administration.
Issar M; Singh SK; Madhusudanan KP; Mishra B; Gupta RC
J Pharm Pharmacol; 2002 Dec; 54(12):1623-30. PubMed ID: 12542891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
